Format

Send to

Choose Destination
Science. 2019 Mar 15;363(6432):1182-1186. doi: 10.1126/science.aaw4892.

Science and health for all children with cancer.

Author information

1
Departments of Global Pediatric Medicine and Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA. catherine.lam@stjude.org.
2
University of Tennessee Health Sciences Center, Memphis, TN, USA.
3
Guardian Research Network, Spartanburg, SC, USA.
4
Board, International Society of Paediatric Oncology (SIOP), Zug, Switzerland.
5
Division of Haematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
6
UCL Great Ormond Street Institute of Child Health, University College London, London, UK.

Abstract

Each year ~429,000 children and adolescents aged 0 to 19 years are expected to develop cancer. Five-year survival rates exceed 80% for the 45,000 children with cancer in high-income countries (HICs) but are less than 30% for the 384,000 children in lower-middle-income countries (LMICs). Improved survival rates in HICs have been achieved through multidisciplinary care and research, with treatment regimens using mostly generic medicines and optimized risk stratification. Children's outcomes in LMICs can be improved through global collaborative partnerships that help local leaders adapt effective treatments to local resources and clinical needs, as well as address common problems such as delayed diagnosis and treatment abandonment. Together, these approaches may bring within reach the global survival target recently set by the World Health Organization: 60% survival for all children with cancer by 2030.

PMID:
30872518
DOI:
10.1126/science.aaw4892

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center